ribavirin has been researched along with Acquired Autoimmune Hemolytic Anemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bel Hadj, N; Ben Nejma, H; Cheikh, M; Ennaifer, R; Hefaiedh, R; Romdhane, H | 1 |
| Al-Ansari, M; Dickson, G; Weilert, F | 1 |
| Antonietti, CL; Brandão-Mello, CE; Campos-de-Magalhães, M; da Silva, ML; de Almeida, AJ; de Oliveira, RV; do Espírito-Santo, MP; Lampe, E; Yoshida, CF | 1 |
| de Man, RA; Dietvorst, MH; van Wijngaarden, P | 1 |
| Bellou, A; Bibashi, E; Gigi, E; Raptopoulou-Gigi, M; Sinakos, E; Sykia, A | 1 |
| Ikeda, N; Nishino, R; Unoura, M | 1 |
| Borgia, G; Borrelli, F; Cerini, R; Ciampi, R; Gentile, I; Piazza, M; Reynaud, L; Viola, C | 1 |
| Bilusic, M; Hrstic, I; Huic, D; Vucelic, B | 1 |
| Balestrieri, C; Cauli, C; Chessa, L; Farci, P; Lai, ME; Scioscia, R; Serra, G | 1 |
1 review(s) available for ribavirin and Acquired Autoimmune Hemolytic Anemia
| Article | Year |
|---|---|
[Autoimmune hemolytic anemia in a case of chronic hepatitis type C 56 weeks after initiation of second line treatment with pegylated interferon alpha2b/ribavirin combination therapy].
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
8 other study(ies) available for ribavirin and Acquired Autoimmune Hemolytic Anemia
| Article | Year |
|---|---|
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2014 |
Interferon-induced haemolytic anaemia in hepatitis C.
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin | 2008 |
Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Platelet Count; Platelet Membrane Glycoproteins; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2009 |
Autoimmune haemolytic anaemia due to chronic hepatitis C virus infection treated with prednisone, pegylated interferon and ribavirin.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prednisolone; Recombinant Proteins; Ribavirin | 2009 |
Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Invasive Pulmonary Aspergillosis; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tomography, X-Ray Computed | 2009 |
Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit.
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Disease Progression; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin | 2006 |
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin.
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Drug Therapy, Combination; Hematocrit; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |